Table 1 Baseline characteristics
Characteristics | Placebo (n = 3) | 0.02% (n = 3) | 0.1% (n = 3) | 0.5% (n = 3) |
|---|---|---|---|---|
Male (%) | 2 (66.7%) | 2 (66.7%) | 2 (66.7%) | 2(66.7%) |
Age (years), mean (SD) | 74.3 (9.5) | 63.3 (14.3) | 61.0 (23.6) | 76.3 (9.1) |
Height (cm), mean (SD) | 155.87 (18.75) | 153.60 (6.59) | 160.33 (13.65) | 163.97 (10.1) |
Weight (kg), mean (SD) | 60.80 (16.20) | 62.90 (12.15) | 52.40 (4.10) | 63.27 (1.50) |
Diagnosis | ||||
Diabetic ulcer | 2 (66.7%) | 2 (66.7%) | 2 (66.7%) | 1 (33.3%) |
Ischemic ulcer | 0 | 1 (33.3%) | 1 (33.3%) | 1 (33.3%) |
Venous ulcer | 1 (33.3%) | 0 | 0 | 1 (33.3%) |
Ulcer position | ||||
Finger | 2 (66.7%) | 1 (33.3%) | 1 (33.3%) | 1 (33.3%) |
Foot | 1 (33.3%) | 1 (33.3%) | 2 (66.7%) | 1 (33.3%) |
Low leg | 0 | 1 (33.3%) | 0 | 1 (33.3%) |
Duration (month) | ||||
<3 | 1 (33.3%) | 2 (66.7%) | 1 (33.3%) | 0 |
3 ≦ <6 | 0 | 1 (33.3%) | 1 (33.3%) | 1 (33.3%) |
6 ≦ <12 | 0 | 0 | 0 | 1 (33.3%) |
12 ≦ <36 | 2 (66.7%) | 0 | 0 | 0 |
36 ≦ | 0 | 0 | 1 (33.3%) | 1 (33.3%) |
